Medline (NASDAQ:MDLN – Get Free Report) shares saw unusually-high trading volume on Wednesday after Zacks Research upgraded the stock from a strong sell rating to a hold rating. 17,499,610 shares were traded during trading, an increase of 124% from the average daily volume of 7,795,192 shares. The stock last traded at $38.8150 and had previously closed at $37.68.
A number of other brokerages have also recently weighed in on MDLN. Stifel Nicolaus reduced their target price on Medline from $50.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 6th. Tigress Financial dropped their price target on Medline from $62.00 to $55.00 and set a “buy” rating for the company in a research note on Tuesday, August 11th. Deutsche Bank set a $37.00 price objective on Medline and gave the stock a “hold” rating in a report on Thursday, August 6th. TD Cowen reduced their price objective on Medline from $53.00 to $45.00 and set a “buy” rating on the stock in a research note on Monday, August 10th. Finally, Evercore set a $39.00 target price on Medline in a report on Thursday, August 6th. Twenty-three investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $46.08.
View Our Latest Report on MDLN
Insider Buying and Selling at Medline
In other news, major shareholder Private Ltd Gic sold 2,088,987 shares of the stock in a transaction dated Tuesday, October 6th. The stock was sold at an average price of $35.05, for a total value of $73,218,994.35. Following the completion of the sale, the insider owned 16,453,806 shares in the company, valued at approximately $576,705,900.30. This trade represents a 11.27% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders sold a total of 6,348,676 shares of company stock valued at $224,525,137 over the last ninety days. 0.81% of the stock is owned by corporate insiders.
More Medline News
These are some of the MDLN news items that stood out recently:
- Positive Sentiment: Several recent valuation articles argue Medline may be undervalued, estimating upside of about 19% to 33%; a separate report says analysts raised fair-value estimates. These are valuation opinions, not guarantees of future performance. Article Article Article
- Neutral Sentiment: Unusually high call-option trading was reported, but options activity alone does not establish a lasting bullish outlook. Medline also introduced right-sized packaging at two distribution centers, a potential operational-efficiency measure with no disclosed financial impact. Company announcement
- Negative Sentiment: Medline has reported additional deaths in connection with its electric-bed recall, raising potential product-liability and reputational concerns. Separately, a law firm announced a securities-fraud investigation; this is an investigation announcement, not a finding of wrongdoing. Article Investigation announcement
Hedge Funds Weigh In On Medline
A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Kentucky Retirement Systems Insurance Trust Fund grew its position in Medline by 10.0% in the third quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 11,431 shares of the company’s stock valued at $397,000 after acquiring an additional 1,036 shares in the last quarter. Kentucky Retirement Systems lifted its position in shares of Medline by 12.7% during the third quarter. Kentucky Retirement Systems now owns 28,241 shares of the company’s stock worth $980,000 after purchasing an additional 3,192 shares in the last quarter. Allworth Financial LP lifted its position in shares of Medline by 36.8% during the third quarter. Allworth Financial LP now owns 1,439 shares of the company’s stock worth $50,000 after purchasing an additional 387 shares in the last quarter. Beck Mack & Oliver LLC acquired a new position in shares of Medline during the third quarter worth $4,245,000. Finally, Worldquant Millennium Advisors LLC boosted its stake in shares of Medline by 144.6% in the third quarter. Worldquant Millennium Advisors LLC now owns 2,647,660 shares of the company’s stock valued at $91,874,000 after purchasing an additional 1,565,422 shares during the period.
Medline Stock Down 3.4%
The firm’s 50 day moving average price is $35.60 and its two-hundred day moving average price is $39.25. The firm has a market capitalization of $49.77 billion and a PE ratio of 86.00. The company has a quick ratio of 2.51, a current ratio of 4.04 and a debt-to-equity ratio of 0.65.
Medline (NASDAQ:MDLN – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.32 by $0.12. Medline had a net margin of 1.84% and a return on equity of 8.21%. The firm had revenue of $7.86 billion for the quarter. As a group, research analysts forecast that Medline will post 1.58 EPS for the current fiscal year.
Medline Company Profile
Medline is a healthcare products manufacturer and distributor serving providers across the care continuum. Its customers include hospitals, surgery centers, physician practices, long-term care facilities and home-care organizations. The company offers a broad range of medical and surgical supplies, including products for infection prevention, wound care and patient care, as well as apparel and equipment. Medline also provides supply-chain and logistics services to healthcare organizations. Founded in 1966, Medline is headquartered in Northfield, Illinois, and serves customers in the United States and internationally.
See Also
- Five stocks we like better than Medline
- Home Depot Posts a Q3 Double Beat, But Is Its Rebound Built to Last?
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
Receive News & Ratings for Medline Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medline and related companies with MarketBeat.com's FREE daily email newsletter.
